These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29944945)

  • 61. Impact of Freeze/Thaw Process on Drug Substance Storage of Therapeutics.
    Rayfield WJ; Kandula S; Khan H; Tugcu N
    J Pharm Sci; 2017 Aug; 106(8):1944-1951. PubMed ID: 28343990
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of mAb Aggregation on Its Biological Activity: Rituximab as a Case Study.
    Bansal R; Dash R; Rathore AS
    J Pharm Sci; 2020 Sep; 109(9):2684-2698. PubMed ID: 32473898
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of Hydrogen Exchange Mass Spectrometry as a Stability-Indicating Method for Formulation Excipient Screening for an IgG4 Monoclonal Antibody.
    Toth RT; Pace SE; Mills BJ; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2018 Apr; 107(4):1009-1019. PubMed ID: 29269271
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunogenicity of protein aggregates of a monoclonal antibody generated by forced shaking stress with siliconized and nonsiliconized syringes in BALB/c mice.
    Uchino T; Miyazaki Y; Yamazaki T; Kagawa Y
    J Pharm Pharmacol; 2017 Oct; 69(10):1341-1351. PubMed ID: 28639328
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Conformation assessment of therapeutic monoclonal antibodies by SEC-MS: Unravelling analytical biases for application to quality control.
    Le-Minh V; Halgand F; Van der Rest G; Taverna M; Smadja C
    J Pharm Biomed Anal; 2020 Jun; 185():113252. PubMed ID: 32193039
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.
    Brummitt RK; Nesta DP; Chang L; Kroetsch AM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2104-19. PubMed ID: 21213307
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T binding.
    Kayser V; Chennamsetty N; Voynov V; Helk B; Trout BL
    MAbs; 2011; 3(4):408-11. PubMed ID: 21540645
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation.
    Kolhe P; Amend E; Singh SK
    Biotechnol Prog; 2010; 26(3):727-33. PubMed ID: 20039442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neural network-based fingerprinting of monoclonal antibody aggregation using biolayer interferometry.
    Budholiya N; Roy S; Rathore AS
    Anal Bioanal Chem; 2020 Apr; 412(9):2177-2186. PubMed ID: 31620826
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effective protocol for the investigation of physicochemical and conformational stability and aggregation kinetics measurements of therapeutic IgG2 monoclonal antibody.
    Aboel Dahab A; El-Hag D
    J Immunol Methods; 2014 Mar; 405():154-66. PubMed ID: 24530566
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Monoclonal antibody higher order structure analysis by high throughput protein conformational array.
    Song Y; Yu D; Mayani M; Mussa N; Li ZJ
    MAbs; 2018 Apr; 10(3):397-405. PubMed ID: 29313446
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™.
    Pisupati K; Benet A; Tian Y; Okbazghi S; Kang J; Ford M; Saveliev S; Sen KI; Carlson E; Tolbert TJ; Ruotolo BT; Schwendeman SP; Schwendeman A
    MAbs; 2017 Oct; 9(7):1197-1209. PubMed ID: 28787231
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Shaken, not stirred: mechanical stress testing of an IgG1 antibody.
    Kiese S; Papppenberger A; Friess W; Mahler HC
    J Pharm Sci; 2008 Oct; 97(10):4347-66. PubMed ID: 18240293
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T binding.
    Kayser V; Chennamsetty N; Voynov V; Helk B; Forrer K; Trout BL
    Biotechnol J; 2012 Jan; 7(1):127-32. PubMed ID: 21953825
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A computational method for predicting the aggregation propensity of IgG1 and IgG4(P) mAbs in common storage buffers.
    Heads JT; Kelm S; Tyson K; Lawson ADG
    MAbs; 2022; 14(1):2138092. PubMed ID: 36418193
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation.
    Kayser V; Chennamsetty N; Voynov V; Helk B; Forrer K; Trout BL
    J Pharm Sci; 2011 Jul; 100(7):2526-42. PubMed ID: 21268027
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies.
    Kayser V; Chennamsetty N; Voynov V; Forrer K; Helk B; Trout BL
    Biotechnol J; 2011 Jan; 6(1):38-44. PubMed ID: 20949542
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metal Ion Interactions with mAbs: Part 2. Zinc-Mediated Aggregation of IgG1 Monoclonal Antibodies.
    Mehta S; Flores H; Walters B; Sreedhara A
    Pharm Res; 2021 Aug; 38(8):1387-1395. PubMed ID: 34382142
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions.
    Yageta S; Lauer TM; Trout BL; Honda S
    Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.